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ABSTRACT: The capacity of metal-dependent fungal and
bacterial polysaccharide oxygenases, termed GH61 and
CBM33, respectively, to potentiate the enzymatic degradation
of cellulose opens new possibilities for the conversion of
recalcitrant biomass to biofuels. GH61s have already been
shown to be unique metalloenzymes containing an active site
with a mononuclear copper ion coordinated by two histidines,
one of which is an unusual τ-N-methylated N-terminal
histidine. We now report the structural and spectroscopic
characterization of the corresponding copper CBM33
enzymes. CBM33 binds copper with high aﬃnity at a
mononuclear site, signiﬁcantly stabilizing the enzyme. X-band EPR spectroscopy of Cu(II)-CBM33 shows a mononuclear
type 2 copper site with the copper ion in a distorted axial coordination sphere, into which azide will coordinate as evidenced by
the concomitant formation of a new absorption band in the UV/vis spectrum at 390 nm. The enzyme’s three-dimensional
structure contains copper, which has been photoreduced to Cu(I) by the incident X-rays, conﬁrmed by X-ray absorption/
ﬂuorescence studies of both aqueous solution and intact crystals of Cu-CBM33. The single copper(I) ion is ligated in a T-shaped
conﬁguration by three nitrogen atoms from two histidine side chains and the amino terminus, similar to the endogenous copper
coordination geometry found in fungal GH61.
■ INTRODUCTION
Controlled degradation of abundant biomass is a sine qua non
for the future success of bioethanol production.1−5 In this
regard, ﬁnding a means of overcoming the recalcitrance of
cellulosic, lignocellulosic, or chitinotic materials either by
chemical or by enzymatic methods is a major objective. Of
these methods enzymatic solutions oﬀer promise especially as
recent months have seen strides toward a fuller appreciation of
the consortia of ligninases, cellulases, and chitinases deployed
by saprophytes and heterotrophs in the degradation of
biomass.2,6−9 In this context, an important recent advance
was the discovery of a class of enzymatic oxidases, and their
action on polysaccharides, reported by Harris et al.10 and Vaaje-
Kolstad et al.,11 who demonstrated that eﬀective fungal and
bacterial depolymerization of polysaccharides hinges upon the
initial action of structure-disrupting enzymes classiﬁed12 as
GH61 and CBM33, respectively. Subsequently, it was shown
that GH61s from Thermoascus aurantiacus and Thielavia
terrestris are new types of copper-dependent oxidases with an
unusual active site, where the copper ion is bound by two
histidines of the so-called histidine brace (Figure 1).13 This
ﬁnding was conﬁrmed for fungal GH61s from Neurospora
crassa14,15 and Phanerochaete chrysosporium.16 The active site is
notable for its τ-N-methylated N-terminal histidine, the
functional requirement of which is unclear. It is also similar
to part of the copper active site of particulate methane
monoxygenase, another powerful copper oxidase.17
In contrast to GH61, however, and despite their potential for
biofuel production, the structural and mechanistic details of
CBM33 enzymes are less certain. While initial structural
reports11 suggested that Na+, Zn2+, or Mg2+ might be the metal
at the active site, these have now been shown to be incorrect as
the activity of a bacterial CBM33 from Enterococcus faecalis18,19
was recently demonstrated also to be copper-dependent.
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Figure 1. Active site structure of Cu(II)-GH61 showing conserved
residues. Site-directed mutagenesis of the coordinated tyrosine/ate
leads to reduction in activity, while mutation of glutamine leads to
inactivation.10 Cu−N(term-his) = 1.9, Cu−N(his) = 2.1, Cu−NH2 =
2.2, Cu···O(Tyr) = 2.9 Å.
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A recent NMR structure (PDB 2LHS) of a CBP21 CBM33
showed that the overall solution structure of CBP21 is similar
to that of the crystallized enzyme, but while Cu perturbs the
histidine NMR signals (allowing pKa determination) showing
the expected coordination of copper at the active site, no details
of the copper coordination geometry could be determined from
this study.20 Also awaiting fuller elucidation is an understanding
of the diﬀerence in mechanisms of action of CBM33 and
GH61. For instance, analysis of the degradation products from
the action of GH61 indicates oxidation at C1, C4, or C6 of the
glycosidic unit, dependent on the subclass of GH61 carrying
out the oxidation.21 In these cases, GH61 action aﬀords a linear
sequence of oligosaccharide products with degrees of polymer-
ization (dp) = 2,3,4,5,etc.13,16,22 In contrast, where studied,
CBM33 oxidation appears only to occur at C1 and aﬀords
principally oligosaccharides with dp = 2,4,6,etc.18,23
From a structural perspective, both enzyme classes exhibit an
overall structure with a beta-sandwich core, which lies roughly
perpendicular to an extended ﬂat face, the center of which
contains the active site. For GH61, substrate-binding at the face
is thought to be mediated mainly by aromatic−carbohydrate
interactions.24,21 In CBM33, a lack of aromatic amino acid side
chains at the binding site suggests that binding to
polysaccharides is mediated through diﬀerent interactions
exempliﬁed by proposals for the interaction of the “CBP21”
chitin-binding CBM33.23
Both GH61 and CBM33 have a functional requirement for a
reducing equivalent, either a sugar dehydrogenase exempliﬁed
by cellobiose dehydrogenase14,22,25,26 or a small molecule
reductant,13 which, along with the need for dioxygen, is
commensurate with a catalytic cycle in which dioxygen
activation at a reduced copper site is a key step. Indeed,
through further structural studies of an oxygenated form of a
Cu-GH61 and in parallel with other known copper oxygenases
such as peptidyl glycine monoxygenase,27 Marletta et al.
speculated on a reaction sequence for GH61 in which,
following the formation of a copper(I) state and addition of
dioxygen, copper(II)-superoxide is a potential oxidative
species.14,15 This proposal is based on a structure of GH61,
which shows the copper ion coordinated in an axially elongated
geometry, with the equatorial plane occupied by the three
nitrogen atoms of the histidine brace. A water molecule
occupies one axial position, and the other axial position has
electron density that is assigned to a superoxide with a Cu···O
distance of 2.9 Å.28 Notwithstanding this structure, in-depth
mechanistic studies are urgently required to examine not only
the proposal of a copper-superoxide but also, and perhaps more
importantly, whether other types of reactive copper−oxygen
species could be formed as part of the reaction cycle.
As part of the continuing drive toward understanding the
mechanisms of action of GH61s and CBM33s, we report here
the isolation, characterization, and full three-dimensional X-ray
structures of the apo and copper-bound forms of a CBM33
from Bacillus amyloliquefaciens. As initially demonstrated by
Aachmann et al., we conﬁrm that copper(II) binding to the apo
enzyme is very tight indeed, and we further show that copper
binding is accompanied by a substantial increase in protein
stability.20 Additionally, using EPR spectroscopy, we reveal
details of the copper coordination sphere, which, in contrast to
GH61, shows the copper ion in a coordination geometry
signiﬁcantly distorted from axial, such that it lies somewhat
between the usual Peisach−Blumberg type 1 and type 2
classiﬁcations.29 Three-dimensional structure and X-ray absorp-
tion spectroscopy studies of the reduced form display a
copper(I) ion in a T-shaped coordination geometry, where the
copper has been photoreduced by the incident X-rays.
■ RESULTS AND DISCUSSION
Protein Isolation, Isothermal Calorimetry, and Ther-
mal Stability. The Bacillus amyloliquefaciens CBM33 domain,
(ﬁrst described as chitin-binding protein ChbB from a
chitinolytic strain of B. amyloliquefaciens;30 hereafter
BaCBM33), was produced from expression of the codon-
optimized gene and subsequent periplasmic secretion in E. coli
allowing processing of the signal peptide to yield the free N-
terminal histidine. Standard puriﬁcation with Q Sepharose and
Superdex columns yielded good quantities of pure protein.
Copper(II) binding to apo-BaCBM33 was followed using
isothermal titration calorimetry (ITC) at 298 K, at pHs 5, 6,
and 7. Copper binding has an apparent KD of 6 nM at pH 5 (c
value >1000), which is comparable to the value of 55 nM
recently found for the binding of Cu(II) to CBP21.20
Copper(II) aﬃnity is lower at higher pH giving KD values of
40 nM at pH 6 (c value = 325) and 80 nM at pH 7 (c = 435),
with a copper to protein stoichiometry of approximately 0.8:1
(Figure 2). The small increase in KD with pH is possibly due to
competition for copper binding from the buﬀers used at higher
pH or potentially from the deprotonation of active site residues
involved in the stabilization of a metal-bound water molecule
(see below for further discussion), although the reasons for
these diﬀerences await a more detailed binding study. In either
case, binding of copper to the enzyme is rapid and tight.
Binding of nickel(II), manganese(II), and zinc(II) at pH 5
was also investigated using ITC, with Zn(II) the only metal
showing any measurable binding (Figure 2). To corroborate
ITC data, the thermostability of the protein was measured in
the presence of these metals. In the presence of Cu(II), the
melting temperature (Tm) increased by 20 K (Figure S2), while
in the presence of Ni(II) and Zn(II), a less signiﬁcant shift of 7
K was observed reﬂecting the lower aﬃnity of CBM33 for these
metals. Mn(II) had no impact on the Tm, suggesting no binding
at all. The potential binding of manganese ions was of interest
because there is a single report of GH61 using Mn as a metal
ion in the absence of copper.16 However, in the case of
Figure 2. Isothermal calorimetry of metal binding to BaCBM33: (A)
Cu(II) at pH 6 (see Figure S1 for other pH measurements), (B)
Zn(II) at pH 5.
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BaCBM33, no Mn binding could be detected, strongly
suggesting that CBM33s are uniquely copper enzymes. We
also note that the enzyme does not bind further copper ions
with any signiﬁcant binding constant, analogous to GH61s and
commensurate with the active site in CBM33s being a
mononuclear copper active site, and in contrast to the dicopper
site proposed for copper methane monoxygenase in which the
histidine brace also appears. Such selective binding of a single
copper corroborates the recent reports from activity assays that
CBM33s should be classiﬁed as mononuclear copper-depend-
ent oxygenases.19
Three-Dimensional Structure from X-ray Diﬀraction.
To investigate the nature of the structure of BaCBM33 in more
detail and, in particular, the copper site, the three-dimensional
structures of BaCBM33 in apo, copper-bound, and copper-
bound/ascorbate-soaked forms were solved by molecular
replacement at resolutions of 1.8, 1.9, and 1.7 Å, respectively.
The structures are analogous to those already reported for
CBM33 and GH61 consisting of a core immunoglobin-like β-
sandwich domain with an adjacent helical bundle (deﬁned as
loop L2 in GH61s, Figure 3).21 As with GH61, the N-terminal
active site is at the center of an extended ﬂat surface (ca. 30 ×
40 Å), which is formed by the helical bundle and the narrow
end of the β-sandwich. This surface presumably interacts in a
face-to-face manner with the surface of the substrate, bringing
the copper into close contact with the polysaccharide.
Structural variation between the active sites of the apo and
both copper-bound forms is minimal, revealing a degree of
preorganization for copper binding (Figure S3), consistent with
the high copper-binding aﬃnity. In the copper-bound form at
the N-terminal histidine active site, well-deﬁned electron
density consistent with a single, fully occupied copper ion
was found, coordinated in a T-shaped conﬁguration of the
histidine brace by the nitrogen atoms of two histidine side
chains and the amino terminus [∠Nhis−Cu−NH2 = 96° and
∠NH2−Cu−Nhis = 98°], with Cu−Nhis distances of 2.0 and 2.0
Å and a longer Cu−N (amino terminus) distance of 2.3 Å
(Figure 4). Unlike GH61, there is no tyrosine/ate present in
the apical position of the coordination sphere, which is replaced
by a phenylalanine in CBM33. Additionally, in contrast to
GH61, the N-terminal histidine is not τ-N-methylated. These
diﬀerences, if indeed present in the wild-type enzyme, would
amount to a signiﬁcant variance in the active site electronics of
the copper site in CBM33 and point toward diﬀering
mechanisms of action between the two enzymes, possibly
dictated by the oxidation requirements of diﬀerent natural
substrates.
Surprisingly, no further signiﬁcant electron density (>0.3 σ)
was found in the primary coordination sphere of the putative
copper(II) ion, inconsistent with the dearth of known small
molecule T-shaped copper(II) complexes. Indeed, only one
genuine copper(II) complex in a N3 T-shaped geometry is
known, and in this complex the EPR spin Hamiltonian values
are markedly diﬀerent from those of Cu(II)-BaCBM33 (see
below for further discussion).31,32 The T-shaped coordination
geometry in the structure of Cu-BaCBM33 is, however,
consistent with a copper(I) formulation, especially because
there is no diﬀerence in copper coordination sphere when the
crystals are soaked with sodium ascorbate and the structure
redetermined. The possibility of a reduced copper oxidation
state is corroborated by small molecule studies of copper-
bis(pyrazolyl) amine ligands, where the nitrogen atoms of the
ligand occupy a T-shaped conﬁguration, and studies of three
coordinate copper in histidylhistidine complexes, both of which
also have high redox potentials.33,34
X-ray Absorption Spectroscopy Studies of Copper
Oxidation State. To conﬁrm the presence of copper(I) in the
structures, we performed a Cu K-edge XANES study both of
the in situ crystal during diﬀraction data collection and of an
aqueous solution of Cu(II)BaCBM33 at pH 5 both before and
after exposure to synchrotron X-rays (Figure 5). X-ray exposure
of a 0.6 mM solution of Cu(II)-BaCBM33 at pH 5 led to the
rapid (after a single scan) formation of a pre-edge feature at
8982−3 eV. This feature could also be generated from the
addition of a solution of reducing agent (sodium ascorbate at
pH 5), which is further known to aﬀord an EPR silent species.
The XANES absorption at 8983 eV is assigned to a 1s to
nonbonded 4p transition of a coordinatively unsaturated
copper(I) ion; this transition is a reliable marker of copper
oxidation state and also of low (<4) coordination number.34−37
Moreover, in this case, the proﬁle of the pre-edge region
Figure 3. Structural representation of Cu-BaCBM33, showing copper
active site on binding face.
Figure 4. Top: Electron density map contoured at 1σ in the active site
of Cu-BaCBM33; see Figure S4 for stereo view. Bottom: Line diagram
of active site; cf., Figure 1 for comparison to active site of GH61.
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matches closely to that of a known small molecule copper(I)
complex in which the copper ion is coordinated in T-shaped
conﬁguration formed by two trans pyrazolyls and one
bridgehead amine,38,39 directly analogous to the observed
copper structure in Cu-BaCBM33.
To link the crystallographic and solution phase studies, we
performed ﬂuorescence XANES studies of the in situ crystal.
Notwithstanding their relatively low signal-to-noise, these
spectra display the same pre-edge feature and behavior as
that observed in solution. We therefore infer that the
BaCBM33 copper-bound structure is of the copper(I) form,
where the copper ion has been unavoidably photoreduced by
the X-rays. This observation underlines the need for very
considerable caution in the interpretation of oxidation state and
coordination geometry in the X-ray structures of copper
enzymes that contain the copper histidine brace structure, a
point convincingly made some years ago by Somerhalter et al.40
and a feature of the early structures of CBM33 and GH61,
which goes some way to explain the confusion about the
identity of the metal ion.10,11
Redox Studies of CuBaCBM33. The ostensibly high redox
potential of CuBaCBM33 implied from the XAS studies was
investigated using the method of titration of Cu(II)-BaCBM33
against a range of redox-active dyes with known redox
potentials, indicating a redox potential for CuBaCBM33 of
between ∼275 and 370 mV (Figure S7). Recent studies of a
Cu-CBP21 yielded a comparable value of the redox couple of
ca. 275 mV at pH 6 (vs SHE).20
The relatively high potential is expected from the low
coordination number of the copper ion in CBM33. This has
also been observed in studies of copper histidylhistidine
complexes.34 Furthermore, low coordinate copper(I) centers
have been proposed to be the sites of reactive-oxygen-species
(ROS) production in copper amyloid-β fragments.36 In both
cases, the redox potential of the copper(I) complex and its
reactivity toward dioxygen is critically dependent on the
balance of three coordinate versus two coordinate copper(I),
which, in the context of GH61 and CBM33, implies a
signiﬁcant role in oxygen activation for the central amino
terminus in the coordination sphere of the copper ion.
Additionally, the principal ROS product in copper amyloid-β
fragments appears to be peroxide rather than superoxide,
requiring the presence of a redox-active tyrosine/ate within the
peptide fragment. A similar situation could occur within GH61
and CBM33, both of which have conserved tyrosines or
tryptophans within their sequences (see below).19,21
X-Band EPR Spectroscopy of met-CuBaCBM33 and
Azide Binding Studies. In the absence of structural
information from X-ray crystallography, the nature of the
copper(II) site in Cu(II)-BaCBM33 was investigated using
frozen solution X-band EPR spectroscopy at 155 K. Cu(II)-
BaCBM33 exhibits a rhombic spectral envelope (gx ≠ gy ≠ gz)
but where the SOMO has signiﬁcant d(x2−y2) character,
indicating a mononuclear copper(II) ion in a single binding site
(Figure 6) with distorted-axial coordination geometry.
Simulation of the spectrum was hampered by the second-
order nature of the perpendicular region, making a determi-
nation of the gx and gy and |Ax| and |Ay| tensor values unreliable.
Spin Hamiltonian tensor values in the parallel direction,
however, could be modeled accurately with gz = 2.25 and |Az|
= 125 G (0.0135 cm−1). These values place Cu(II)-BaCBM33
between the usual Peisach−Blumberg classiﬁcations of type 1
and type 2 copper enzymes, although the overall axial envelope
of the EPR signal would suggest that a type 2 classiﬁcation is
appropriate.29 The somewhat low |Az| value in combination
with low gz could arise from increased metal−ligand covalency
or, more likely given the rhombicity of the spectrum and the
potential absence of ligands on the z-axis (see structure
discussion below), a coordination geometry at the copper that
is distorted away from a local axial symmetry, possibly by the
coordination of one or two water molecules, neither of which is
directly trans to the amino terminus. This distortion allows the
SOMO to mix with 3d(z2) and/or 4s orbitals, aﬀording a
greater relative contribution of spin-dipolar and/or Fermi
contact terms to the hyperﬁne coupling.41,42 Additional
evidence for a distorted coordination geometry comes from
noting the similarity of the gz and |Az| values for Cu(II)-
BaCBM33 with those of the copper site in Cu−Zn superoxide
dismutase, in which the copper has a distorted square planar
coordination geometry.43 Furthermore, an existing X-ray
Figure 5. Left: 0.6 mM Cu-BaCBM33 solution at pH 5 (1 eV steps).
Right: In crystallo (0.5 eV steps), successive Cu K-edge XANES
ﬂuorescence spectra (black line followed by red line) showing growth
of pre-edge peak at 8982−3 eV. Blue spectrum (oﬀset in ordinate for
clarity) is that of Cu-BaCBM33 solution/crystal pretreated with
sodium ascorbate solution.
Figure 6. X-Band (9 GHz, 155 K) EPR spectrum (top) with
simulation in red (bottom) of Cu(II)BaCBM33 at pH 5 (15% v/v
glycerol).
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structure of a CBP21, which, despite the incorrect assignment
of the metal ion as Na+ at the active site (PDB entry 2BEM),
exhibits a distorted square planar coordination at the metal
where the three nitrogen atoms of the histidine brace and the
metal ion occupy a plane and where a water molecule in the
fourth coordination site is signiﬁcantly deviated from this
plane.11
Addition of sodium azide to a solution of Cu(II)BaCBM33
at pH 5 aﬀords changes in both UV/vis and EPR spectra. In the
latter, addition of stoichiometric azide gives a shift in gz to 2.23
and |Az| to 0.0125 cm
−1, but no change in the overall spectral
envelope. Addition of a 10-fold excess of azide aﬀords a
signiﬁcant change with the formation of new peaks but with
loss of some of the ﬁne structure (Figure S5), indicative of
coordination to the copper(II) center. In the UV/vis spectrum,
a single intense band (ca. 900 dm3 mol−1 cm−1) appears at
∼390 nm assignable to an azide to copper charge transfer band
at a mononuclear copper site.44 The appearance of this band is
accompanied by a small increase in the intensity of the d−d
transition absorption of the Cu(II) center at ca. 690 nm (Figure
6).
There are distinct diﬀerences in the EPR spectrum of Cu(II)-
BaCBM33 and that of Cu(II)-TaGH61. In the latter, the gz and
|Az| values of 2.27 and 0.0162 cm
−1 place GH61 squarely within
the type 2 classiﬁcation of copper site and are also indicative of
a copper(II) ion within an axial coordination geometry. This
geometry was conﬁrmed by the subsequent X-ray diﬀraction
studies of GH61. It is currently unclear why there are such
diﬀerences in the coordination geometries of the met forms of
both CBM33 and GH61, but the diﬀerence is likely to be of
functional signiﬁcance given the diﬀerences in the copper active
site structures of CBM33 and GH61 (see below).
Sequence Conservation Analysis of CBM33s and
Comparison to CBP21 and GH61s. An amino acid sequence
alignment of BaCBM33 with a range of selected CBM33s is
shown in Figure S6. Outside the active site histidines, strict
conservation is observed in parts of the β-sandwich and in a
collection of tryptophan residues adjacent to the active site,
where the latter is probably associated with an electron transfer
function. This particular conservation of tryptophans is also
observed in CBP21 chitin oxidases, as previously noted by
Vaaje-Kolstad et al.19
An unusual feature in CBM33 is observed in the strict
conservation of an alanine residue at position 123 at the end of
a β strand. The methyl group of this alanine is close to the
apical coordination site on the copper ion (Cu···C = 3.9 Å),
thereby providing a degree of steric congestion at this
coordination site. What makes this feature notable is that the
opposite apical site is occupied by a highly conserved
phenylalanine side chain (position 196), which has a near
“end-on” aspect to the copper ion with a closest Cu···C
distance of 3.7 Å (Figure 7). The combination of the alanine
and phenylalanine suggests that coordination to the copper in
CBM33 is restricted to equatorial sites only (Figure 7). This is
in sharp contrast to GH61 where the apical sites are occupied
by the oxygen atoms of a tyrosine/ate and a water molecule,
where the water molecule could be replaced by either substrate
or an oxygen molecule, as suggested by Li et al.21 Whatever the
reasons for the diﬀerences between CBM33 and GH61, the
contrasting arrangement of amino acid side chains in the
copper ions’ secondary coordination spheres, including that of
the τ-N-methylated N-terminal histidine in GH61, is indicative
of diﬀerent mechanisms of action between the two enzymes.
In a further indication of alternative mechanisms, the
conserved residues on the binding face of CBM33 diﬀer from
that of GH61s. In the former, the principal conservation pattern
is found in amino acid side chains, which can engage in
hydrogen-bond interactions with a polysaccharide substrate.
These residues lie in two areas immediately adjacent to the
copper active site. The two regions lie on opposite sides of the
copper ion, thus providing an environment that likely directs a
speciﬁc orientation of the substrate with respect to the copper
and thus any reactive oxygen species generated at the active
site. Such a directed interaction with the substrate is in
accordance with the observation that CBM33s react principally
at the C1 site of β-linked polysaccharides; it may also oﬀer an
explanation as to why only even-numbered oligosaccharides are
produced by CBM33 insofar as the up−down−up−down
orientation pattern of individual glycoside units within chitin
and cellulose will only project C−H bonds (from C−1) toward
the enzyme binding face every other glycosidic unit, as ﬁrst
suggested by Vaaje-Kolstad et al.19,23
GH61s appear to bind to substrate through multiple
aromatic−carbohydrate interactions. This was shown by Li et
al., who identiﬁed conserved tyrosine residues on the α-helical
L2 loop in polysaccharide oxygenases and also on residues near
the copper active site (Figure 8).21 The residues are not only in
diﬀerent positions on the binding face when compared to
CBM33s, but also probably interact with the cellulose substrate
in a somewhat less directional way than the potential hydrogen-
bonding interactions seen in CBM33. This is commensurate
with a wider range of oxidation sites on cellulose that is
observed with GH61 oxidative action, especially type 3
PMOs,21 and that oxidation does not only occur at the
exposed C1−H bonds on cellulose, as appears to be the case in
CBM33.
It is not possible to be more deﬁnitive about the conservation
diﬀerences between CBM33 and GH61 because we are unable
to rule out the possibility of post-translational modiﬁcations on
Figure 7. Active site conserved residues in CBM33 depicting the
occlusion of Cu(II) axial coordination sites by alanine 123 and
phenylalanine 196. Sections of the sequence alignment with two other
CBM33s (B.a = Bacillus amyloliquefaciens, S.m = Serratia marcescens,
and E.f = Enterococcus faecalis)19,23 are shown surrounding each of the
active site residues, which are shown in bold. Their associated
percentage identities from the full sequence alignment shown in Figure
S6 are indicated by the histograms below the sequences according to
the key.
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CBM33, which could introduce extra functionality at the active
site, for instance, oxidation of phenylalanine to tyrosine and
potential methylation of the N-terminal histidine. Indeed, we
observe here that one CBM33 sequence naturally has a tyrosine
in place of phenylalanine 196. Nor can we completely rule out a
coordinative role for a highly conserved tyrosine at position
197, although note that this appears to be unlikely given the
large structural disruption this would entail and the absence of
any conformational ﬂexibility in this region as observed across
several sets of deposited coordinates. Additionally, an inter-
rogation of the CAZy database shows that GH61s can appear as
multidomain proteins in which the oxygenase domain is fused
to other known cellulose-binding modules (e.g., CBM1)
through which binding to cellulose will be signiﬁcantly
aﬀected.45 Similarly, CBM33 enzymes are often appended to
diverse other protein modules involved in hydrolysis and
binding of carbohydrates, as reviewed recently by Horn et al.4
Notwithstanding these caveats, however, a structural basis for
the known diﬀerences in mechanisms of action of CBM33s and
GH61s does emerge without the need to introduce signiﬁcant
post-translational modiﬁcations in CBM33s, and may well
therefore be a reliable basis for understanding diﬀerences in
reactivity.
■ CONCLUSIONS
We have demonstrated that a CBM33 from Bacillus
amyloliquefaciens binds copper(II) with a Kd ≈ 6 nM. This
binding signiﬁcantly stabilizes the enzyme, probably reﬂecting
the increased formation of a folded state of the protein
backbone. From X-band EPR spectroscopy and azide binding
studies, we can infer that Cu-BaCBM33 is a mononuclear type
2 copper enzyme, but where the copper(II) ion has a distorted
axial geometry, possibly a distorted square planar conﬁguration
akin to that seen in structure of Cu−Zn superoxide dismutase.
XANES spectroscopy demonstrates that the copper is
susceptible to reduction and is readily photoreduced by X-
rays both in solution and in the solid state to the copper(I)
form, an observation supported by the high redox potential of
Cu-BaCBM33. (Very recently, structures of a CBM33 from
Enterococcus faecalis were released on the pdb, the deposition
titles of which imply a similar photoreduction of copper when
coordinated by the histidine brace; pdb codes: 4alr, 4als, 4alt,
4alq, 4ale, 4alc. Currently, no further publication accompanies
the release of these coordinates.) Single-crystal X-ray diﬀraction
shows that the enzyme adopts an active site structure, which
has broad parallels with that reported for Cu-GH61s. The
copper(I) histidine brace coordination geometry in Cu-
BaCBM33 is T-shaped N3, corroborated by XANES studies
that show a 1s to nonbonded 4p transition characteristic of low
coordination number copper(I) species. Diﬀerences in the
secondary coordination sphere of the copper ion in CBM33s
and GH61s are suggestive of a diﬀerent mechanism of action in
the two classes of enzymes, but a fuller understanding of the
mechanism awaits in-depth and detailed reaction studies on the
enzymes and their associated small molecule model complexes.
■ EXPERIMENTAL PROCEDURES
Expression and Puriﬁcation of BaCBM33. The coding sequence
of Bacillus amyloliquefaciens CBM33 (NCBI Reference Sequence:
NC_014551.1) from nucleotide 82 to 621 was codon optimized for
expression in Escherichia coli, synthesized with a pelB leader sequence
to direct the protein to the periplasm, and cloned into the pET-11a
vector, by GenScript. The resulting pET11a-BaCBM33 construct was
used to transform BL21 (DE3) E. coli, which were grown from a single
colony in six 500 mL LB cultures to an A600 of 0.4 at 37 °C shaking at
180 rpm. The temperature was then reduced to 16 °C, and the cells
were allowed to grow further to an A600 of 0.6−0.8 when expression
was induced by the addition of IPTG to a ﬁnal concentration of 1 mM.
The cultures were left overnight before the cells were harvested by
centrifugation at 11 000g for 30 min at 4 °C.
Cells were immediately resuspended in 5 volumes of ice cold
resuspension buﬀer (50 mM Tris pH 8.0, 200 mM NaCl, 20% w/v
sucrose). To isolate the periplasmic fraction, 40 μg of hen egg white
lysozyme (Sigma-Aldrich) was added for every gram of cell paste and
left on ice for 1 h. 60 μL of 1 M MgSO4 was then added per gram of
cell paste, and the suspension was incubated for a further 20 min on
ice. Cell debris was then removed by centrifugation at 10 000g, 4 °C
for 10 min, and the supernatant containing the periplasmic fraction
was removed into a fresh tube. This was diluted 4 fold with buﬀer A
(50 mM Tris pH 8.0) and passed through a 5 mL HiTrap Q
Sepharose column equilibrated in the same buﬀer collecting the ﬂow
through. The column was then stripped with 100% buﬀer B (50 mM
Tris pH 8.0, 2 M NaCl). BaCBM33 did not bind to the column and
was present in the ﬂow through, which was precipitated by the
addition of solid ammonium sulfate to a ﬁnal concentration of 3.5 M
and left stirring overnight at 4 °C. The protein was then isolated by
centrifugation at 38 000g for 30 min, the supernatant was discarded,
and the pellet was dissolved in 10 volumes of buﬀer C (20 mM sodium
acetate pH 5.0, 250 mM NaCl, 5 mM EDTA). The protein was then
concentrated to less than 10 mL and applied to a HiLoad 26/60
Superdex 75 column equilibrated in GF buﬀer (20 mM sodium acetate
pH 5.0, 250 mM NaCl). Peak fractions containing pure BaCBM33
were pooled and concentrated using a Sartorius 10 kDa cut oﬀ
concentrator at 4000g. Protein concentrations for all subsequent
experiments were determined by measuring the A280 using an
extinction coeﬃcient of 44 920 M−1 cm−1 and a molecular weight of
19 821 Da.
Redox Potential Measurements. The redox indicator dyes
thionine, tetramethylphenylenediamine (TMP), and 2,6-dichloro-
phenolindophenol (DCPIP) were purchased from Sigma. A three-
electrode setup was used to determine accurately the reduction
potential of the redox indicators and potassium ferricyanide in 100
mM sodium acetate buﬀer, pH 5. A stationary Pt disc working
electrode (BASi), a Pt wire counter electrode, and a saturated calomel
reference electrode (SLS) were all placed into an all-glass electro-
chemical cell. Cyclic voltammograms (50 mV s−1) were measured for 1
mM solutions of each of the redox compounds under a ﬂow of Ar. A
correction factor of ESHE = ESCE + 0.241 V was used. The resultant
scans are shown in Figure S7. The anodic and cathodic peak potentials,
as determined by the electrochemical software (Epsilon BASi), were
averaged to give the midpoint reduction potentials, summarized in
Figure 8. Binding face of BaCBM33 indicating conserved residues.
Region colored red is copper active site, which is surrounded by highly
conserved regions consisting of residues capable of forming hydrogen
bonds with substrate. L2 loop region is to bottom right of ﬁgure,
showing no noticeable conservation, in contrast to type 2 PMOs
(GH61s), which exhibit conservation of some aromatic residues.21
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Table S2. To judge if the dye could reduce BaCBM33, up to 10 μL of
approximately 0.5 mM enzyme was injected into a suba-sealed cuvette
containing 150 μL of reduced dye solution (absorbance <0.2 AU) and
a small stirrer bar. Following 2 min of stirring, any resulting color
changes were monitored using UV−vis spectroscopy. Control
experiments were conducted with injection of buﬀer instead of
enzyme, and it was conﬁrmed that CBM33 was required to oxidize
thionine or TMP in the cuvette.
EPR Spectroscopy. Continuous wave X-band frozen solution EPR
spectra of 0.5 mM solution of Cu(II)-BaCBM33 (15% v/v glycerol) at
pH 5 (acetate buﬀer) and 155 K were acquired on a Bruker ESP 300
spectrometer operating at 9.072 or 9.35 GHz, with a modulation
amplitude of 4G and microwave power of 5 mW. Spectra were
referenced against DPPH. Spectral simulation was carried out using
Easyspin 4.0.0 on a desktop PC. Simulation parameters were as
follows: gx = 2.075, gy = 2.086, gz = 2.255; |Ax| = 39, |Ay| = 90, |Az| =
125 G. Strain: Axx = 210, Ayy = 210, Azz = 210 G. Linewidth: 40 G
(Gaussian), 40 G (Lorentzian). gz and |Az| were determined accurately
from the two absorptions at low ﬁeld where it was assumed that these
absorptions were separated from other aspects of the absorption
envelope. It was assumed that g and A tensors were axially coincident.
Accurate determination of the gx, gy, |Ax|, and |Ay| was not possible due
to the second-order nature of the perpendicular region and the
signiﬁcant level of conformational heterogeneity, although it was noted
that satisfactory simulation could only be achieved with one particular
set of spin Hamiltonian values.
Solution XANES Spectroscopy. XANES spectroscopy data were
collected on a 0.6 mM solution of Cu(II)-BaCBM33 at pH 5, which
had been ﬂash-frozen to 77 K (0.7 mM BaCBM33 was prepared in 20
mM sodium acetate pH 5.0, 250 mM NaCl to which Cu(NO3)2·3H2O
was added to a ﬁnal concentration of 0.6 mM; to produce a Cu(I)
sample, ascorbate was added to a ﬁnal concentration of 10 mM). Data
were acquired on the sample at 90 K at the B18 Core Spectroscopy
beamline at Diamond Light Source, Oxfordshire, UK. At the time of
the measurement, the Diamond synchrotron was operating at a ring
energy of 3 GeV in a 10 min top-up mode for a ring current of 301
mA. The beamline was equipped with a Si(111) double crystal
monochromator, and harmonic rejection was achieved through the use
of two Pt-coated mirrors operating at an incidence angle of 9 mrad.
The monochromator was calibrated using the ﬁrst maximum in the
derivative in the edge region of the XAS spectra of a copper foil placed
between the second and third ion chambers at 8979 eV. Estimated ﬂux
of beam at 8 keV = 5 × 1011 ph/s. Data were collected in ﬂuorescence
from 8779 to 9020 eV using a nine-channel Ge solid-state detector at
the copper K absorption edge (∼8980 eV) in 1 eV steps. The sample
was contained in a 5 mm light path PTFE 400 μL cell with 25 μm
thick windows made from Kapton foil. The measurements were made
at 90 K. The incident beam intensity was measured using a 30 cm ion
chamber optimized using a helium−nitrogen gas mixture to absorb
30% and 70% of the beam in I0, respectively.
XANES Data Collection in the Crystal. X-ray ﬂuorescence scans
were performed on crystals, which had not previously been exposed to
X-rays on station I03 of Diamond Light Source, using a Vortex
multicathode, single element detector. Crystals from copper
cocrystallizations, as grown for the structure determination, were
washed through three drops of cryo-protectant solution to remove
excess copper prior to plunging in liquid nitrogen. To produce Cu(I)
control samples, 20 mM ascorbate was included in the cryo-protectant
soaking solution. Fluorescence scans were performed across the
copper K-edge from 8942 to 9017 eV with step sizes of 5 eV from
8942 to 8962 eV, 0.5 eV across the edge from 8962 to 8997 eV, and 5
eV from 8997 to 9017 eV.
Isothermal Titration Calorimetry. Isothermal titration calorim-
etry was performed using a VP-ITC calorimeter (MicroCal). Typically
protein was present in the cell between 10 and 120 μM with a 10-fold
more concentrated solution of CuCl2 in the syringe. Titrations were
initially performed at 283 K, but the same results could later be
obtained at 298 K also. After an initial 2 μL injection, which is
discarded in the data analysis, 10 μL injections were used during the
titration with a 5 min interval between each injection at pH 5.0 and 6.0
and 8 min intervals at pH 7.0 where binding was slower. The buﬀers
used during the titrations were either 20 mM sodium acetate pH 5.0,
250 mM NaCl, 20 mM Bis-Tris pH 6.0, 250 mM NaCl, or 20 mM Bis-
Tris pH 7.0, 250 mM NaCl with the CuCl2 solution prepared in
exactly the same buﬀer. All data were analyzed using the Origin 7
software package (MicroCal). Heats of dilution were subtracted from
the data, but the analysis routinely returned a substoichiometric
binding of Cu. Modiﬁcation of the injection system to remove Cu-
containing brass components improved the stoichiometries, but these
rarely exceeded 0.86. This is likely due to a portion of the protein
having acquired Cu2+ given the very high aﬃnity of the interaction
from the glassware. To give meaningful ΔH values (the KDs are
unaﬀected), the protein concentration was therefore adjusted in the
software to reﬂect the 1:1 stoichiometry of copper to protein seen in
the crystal structure.
Diﬀerential Scanning Fluorimetry. Diﬀerential scanning ﬂuo-
rimetry was used to determine the melting temperature of BaCBM33
with and without metal ions. Stability measurements were performed
using an Agilent MX3000P QPCR machine and the ﬂuorescent dye
SYPRO orange (Sigma-Aldrich) diluted 2000 fold from the stock
solution. Fluorescence was measured with excitation and emission
wavelengths of 517 and 585 nm, respectively. All experiments were
performed in 20 mM sodium acetate pH 5, 250 mM NaCl with
protein at 25 μM, and a total volume of 30 μL. Fluorescence was
monitored while increasing the temperature in steps of 1 °C at 30 s
intervals from 25 to 96 °C. The ﬂuorescence was signiﬁcantly
quenched in the presence of copper, but a melting curve could still be
obtained. Melting temperatures (Tm) were calculated by ﬁtting a
sigmoidal curve to the data using the MTSA46 program for MATLAB.
Crystallization of Apo and Cu-Bound BaCBM33. To form the
Cu complex, Cu(NO3)2·3H2O was added to the protein to a ﬁnal
concentration of 1 mM. Apo and Cu cocrystallization trials were then
set up in parallel with a protein concentration of 7 mg/mL using a
Mosquito robot (TTP Labtech). The best crystals in both cases were
obtained in condition D1 of the PACT screen (Qiagen): 0.1 M MMT
buﬀer pH 4.0, 25% PEG-1500. Crystals were used directly from these
initial screens for subsequent data collection. Crystals used to
determine the Cu-bound/ascorbate soaked structure were cocrystal-
lized with copper in the same way as described above.
Diﬀraction Data Collection, Processing, and Structure
Determination. Crystals were cryo-cooled for data collection by
ﬁrst soaking for 30 s in mother liquor supplemented with 20% v/v
ethylene glycol before plunging directly in liquid nitrogen. For the
ascorbate soak, 20 mM sodium ascorbate was included in the cryo-
protectant. Diﬀraction data were collected at Diamond Light Source,
beamlines I04-1 and I03 at wavelengths of 0.917 and 0.976 Å,
respectively. Data were indexed and integrated using XDS47 with
subsequent processing performed using the CCP4 software package.48
The Serratia marcescens CBP21 structure (pdb 2ben)49 was prepared
as a molecular replacement search model using CHAINSAW,50 cutting
back side chains to their nearest common atom. The Apo and Cu-
bound structures were initially determined by molecular replacement
using PHASER,51 both containing two molecules in the asymmetric
unit. Following structure solution, pseudotranslational symmetry was
detected in the apo-BaCBM33 data. The structure was therefore
solved again using MOLREP inputting the pseudo translation vector
0.500, 0.000, 0.127 for the oﬀ-origin Patterson peak. ARPwARP52 was
then used to rebuild the initial models before subsequent manual
building and reﬁnement using COOT53 and REFMAC5,54 respec-
tively. Local NCS restraints were applied using the automatic NCS
option in REFMAC5. The ascorbate soaked crystals were
isomorphous to the copper-free crystals, and so the copper-free
structure was simply reﬁned against these data, with waters and ﬂexible
loops removed, to yield the structure. This was rebuilt and reﬁned with
COOT and REFMAC5 as for the others. All data processing and
reﬁnement statistics can be found in Table S1. Coordinates and
accompanying structure factors for the apo-, Cu-bound, and Cu-
bound/ascorbate soaked enzyme have been deposited in the protein
data bank with accession codes 2YOW, 2YOX, and 2YOY,
respectively.
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